News

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...
WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced ...
But the Trump administration’s cuts to HIV programs in the U.S. and abroad could undermine the drug’s rollout.
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...
The Genesee County Health Department is offering no-cost testing during National HIV Testing Day at the Genesee Free Medical ...
A new HIV prevention shot that requires just two injections a year has received FDA approval after clinical trials showed it ...
Pharmaceutical company Gilead Sciences announced Wednesday the Food and Drug Administration (FDA) has approved its six-month, twice-yearly HIV PrEP injection, which was found in trials to be more ...
WASHINGTON - The Food and Drug Administration on Wednesday approved Gilead Sciences' lenacapavir, a twice-yearly injection ...
A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...
The launch of the injection faces potential threats, including the Trump administration’s proposed cuts to federal funding ...